Zika

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Xpert® Tropical Fever Test on GeneXpert® Edge X System

Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities

Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale

Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu

Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia

Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating

Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia

Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)

International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy

Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

Baromètre Santé Adulte 2021-2022

GLS-5700 in Dengue Virus Seropositive Adults

Defining Skin Immunity of a Bite of Key Insect Vectors in Humans

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria

Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study